Singapore 10/29/10—Agilent Technologies has opened a life sciences instrument manufacturing facility in Singapore to produce its LC/MS systems. The facility will produce the company’s 6100 series Single Quadrupole LC/MS, 6200 series Accurate-Mass Quadrupole TOF LC/MS, 6400 series Triple Quadrupole LC/MS and 6500 series Accurate-Mass Quadrupole TOF LC/MS. “Singapore is the ideal location for this facility […]
Menlo Park, CA 10/26/10; Washington, DC 10/26/10; New York, NY 10/27/10—DNA sequencer developer Pacific Biosciences completed its IPO (see IBO 8/31/10, 10/15/10) on October 26, selling 12.5 million shares of its common stock at $16 per share, which was the mid-range of its pricing. The sale raised $200 million, according to an SEC filing. Shares […]
Although fiscal 2010 figures related to American Recovery and Reinvestment Act (ARRA) funding are not yet available, fiscal 2009 figures have been released for the research-oriented agencies that were major recipients (see IBO 2/28/09). The National Institutes of Health (NIH) reported that fiscal 2009 ARRA-obligated, ARRA-funded awards totaled $1,354 million. An August report released by […]
Prior to the end of the US federal government’s fiscal 2010 on September 30, President Obama signed a continuing resolution to extend federal government funding at current levels until December 3. The 12 fiscal 2011 budget bills have yet to pass Congress. The final budget and its passage is dependent on the outcome of November‘s […]
Second-quarter revenues for IBO’s Lab Equipment/Consumables Sales Index grew 4.6%, 4.7% excluding currency, to $4,183.68 million. While most companies reported increased revenue growth due to the general economic recovery, certain businesses were still negatively impacted by capital restrains. Operating profits for the Index climbed 13.7% to $709.32 million, and adjusted operating margins improved 140 basis […]
Washington, DC 10/4/10—DNA sequencer developer Pacific Biosciences has updated its IPO filing with the SEC, stating that it plans to offer 12,500,000 shares of common stock at a price of $15–$17 per share. The company expects proceeds of $182.5 million. Of this amount, $60–$70 million would be used for applications of SMRT technologies, $40–$60 million […]
Spending by US universities on science and engineering (S&E) R&D grew 5.8% to $54,935 million in fiscal 2009 (ended September 30, 2009), according to a survey of 711 institutions by the National Science Foundation (NSF). Such spending accelerated last year, compared with fiscal 2008, when it grew 4.9%. Adjusted for inflation, fiscal 2009 expenditures rose […]
Although the macroeconomic outlook remains positive, signs of slowing worldwide growth have increased uncertainty among businesses. This uncertainty is reflected in the latest IBO Business Climate Survey. Instrument and lab product sales are expected to be stable, but the fallout from the global recession continues to affect growth. Also, intellectual property concerns related to doing […]
US equity markets soared in September following positive corporate results, renewed M&A activity, lower unemployment claims, increased consumer spending and better-than-expected manufacturing data. In addition, on September 20, the National Bureau of Economic Research officially confirmed that the US recession ended in June 2009, further arousing investors’ optimism. As a result, the Dow Jones Industrial […]
Singapore and Hong Kong, 9/30/10—Lab product manufacturer and distributor Techcomp has announced that it plans to expand its presence in the Chinese health care market. The company will introduce new diagnostic products, including a CE-marked microplate reader and automatic immunoassay system. In addition, Techcomp will establish a new division in its sales channel for the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
